12:00 AM
May 21, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Curcumin: Phase I/II started

Cancer Research and the National Institute for Health Research Experimental Cancer Medicine Center began an open-label, U.K Phase I/II trial to evaluate once-daily curcumin tablets plus FOLFOX...

Read the full 124 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >